Please login to the form below

Not currently logged in
Email:
Password:

Betmiga

This page shows the latest Betmiga news and features for those working in and with pharma, biotech and healthcare.

Eylea's UK launch earns Bayer PMEA success

Eylea's UK launch earns Bayer PMEA success

strategy. Other companies recognised in the category included Astellas, which was highly commended for its launch of overactive bladder treatment Betmiga, while Astellas and Shire were both finalists.

Latest news

  • Germany’s IQWiG denies Astellas’ incontinence drug Germany’s IQWiG denies Astellas’ incontinence drug

    IQWiG determined that Betmiga had a superior side effect profile to tolterodine as there were fewer incidences of dry mouth. ... The decision is in contrast to the positive guidance from the UK's National Institute for Health and Care Excellence (NICE),

  • NICE recommends Astellas' Betmiga for overactive bladder NICE recommends Astellas' Betmiga for overactive bladder

    NICE recommends Astellas' Betmiga for overactive bladder. Final draft guidance recommends Vesicare successor. ... Betmiga was approved by the European Commission in January 2013, adding to its existing approvals in Japan and the US.

  • European approval for Astellas' first-in-class bladder drug Betmiga

    European approval for Astellas' first-in-class bladder drug Betmiga. Will compete with Pfizer's Detrol and Astellas' own Vesicare. ... However, the company will have to be careful with how it positions Betmiga to avoid undermining Vesicare's position.

More from news
Approximately 3 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • Astellas: Ten years young Astellas: Ten years young

    In Europe we have been launching a product almost every single year,” notes Ken, pointing to products such as the overactive bladder (OAB) drug Betmiga (mirabegron) - the first of a new

  • Interview: Kay Drake and Naoki Okamura, Astellas Interview: Kay Drake and Naoki Okamura, Astellas

    However, we have also just launched Betmiga in the UK, developed in-house, which sits in a similar prescribing OAB space, but with a novel mode of action.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M3 (EU)

M3 was founded in 2000 with the goal of changing the world of medicine through making full use of the...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics